Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate

被引：0
|
作者：
Sang-Won Lee
Hee-Jin Park
Beom Kyung Kim
Kwang-Hyub Han
Soo-Kon Lee
Seung Up Kim
Yong-Beom Park
机构：
[1] Yonsei University College of Medicine,Department of Internal Medicine
[2] Yonsei University College of Medicine,Institute for Immunology and Immunological Diseases
[3] Yonsei University College of Medicine,Department of Medical Sciences
[4] Yonsei University College of Medicine,Institute of Gastroenterology
[5] Yonsei University College of Medicine,Liver Cirrhosis Clinical Research Center
来源：
Arthritis Research & Therapy | / 14卷
关键词：
Rheumatoid Arthritis; Rheumatoid Arthritis Patient; Chronic Liver Disease; Liver Fibrosis; Cumulative Dose;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Pancytopenia in rheumatoid arthritis patients receiving methotrexate
    Laroche, F
    Perrot, S
    Menkes, CJ
    REVUE DU RHUMATISME, 1996, 63 (05): : 381 - 382
  • [22] Risk of liver disease in patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis receiving methotrexate: A population-based study
    Gelfand, Joel M.
    Wan, Joy
    Zhang, He
    Shin, Daniel B.
    Ogdie, Alexis
    Syed, Maha N.
    Egeberg, Alexander
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 84 (06) : 1636 - 1643
  • [23] Methotrexate with leflunomide increases risk of pancytopenia
    Reactions Weekly, 2007, 1143 (1) : 4 - 4
  • [24] Assessment of liver fibrosis by transient elastography in rheumatoid arthritis patients treated with methotrexate
    Park, Sung-Hoon
    Choe, Jung-Yoon
    Kim, Seong-Kyu
    JOINT BONE SPINE, 2010, 77 (06) : 588 - 592
  • [25] The relationship between dose of methotrexate and incidence of liver fibrosis in patients with rheumatoid arthritis
    Akbarirad, Mina
    Rezaieyazdi, Zahra
    Tajik, Ali
    Ataei, Banafshe
    Sarabi, Mehrdad
    Mehradmajd, Hasan
    Vossoughinia, Hasan
    Firoozi, Abdollah
    REUMATOLOGIA, 2025, 63 (01): : 3 - 11
  • [26] LIVER FIBROSIS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH METHOTREXATE: HYPOALBUMINEMIA, THE BIOLOGICAL PITFALL
    Lahmar, W.
    Slouma, M.
    Mohamed, G.
    Dhrif, O.
    Abdelli, N.
    Metoui, L.
    Dhahri, R.
    Gharsallah, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1437 - 1437
  • [27] OSTEOPOROSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS: METHOTREXATE COMPARED WITH LEFLUNOMIDE TREATMENT ALONE
    Ganea, N.
    Groppa, L.
    Russu, E.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S324 - S325
  • [28] Association between cumulative methotrexate dose and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate
    Sriram, P. B.
    Venkateswaran, A. R.
    Premkumar, K.
    Chezhian, A.
    Murali, R.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 239 - 239
  • [29] Levofloxacin treatment in patients with rheumatoid arthritis receiving methotrexate
    Ogrendik, Mesut
    SOUTHERN MEDICAL JOURNAL, 2007, 100 (02) : 135 - 139
  • [30] The concomitant use of meloxicam and methotrexate does not clearly increase the risk of silent kidney and liver damages in patients with rheumatoid arthritis
    Park, Hee-Jin
    Park, Min-Chan
    Park, Yong-Beom
    Lee, Soo-Kon
    Lee, Sang-Won
    RHEUMATOLOGY INTERNATIONAL, 2014, 34 (06) : 833 - 840
12345